Skip to main content
ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.480
0.00 (0.00%)
Apr 29, 2026, 12:53 PM EDT - Market open

ProQR Therapeutics Revenue

In the year 2025, ProQR Therapeutics had annual revenue of 16.35M EUR, down -16.36%. ProQR Therapeutics had revenue of 4.72M in the quarter ending December 31, 2025, with 6.14% growth.

Revenue (ttm)
16.35M EUR
Revenue Growth
-16.36%
P/S Ratio
7.90
Revenue / Employee
87,605 EUR
Employees
187
Market Cap
155.93M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202516.35M-3.20M-16.36%
Dec 31, 202419.55M12.95M196.41%
Dec 31, 20236.59M2.24M51.27%
Dec 31, 20224.36M1.98M83.31%
Dec 31, 20212.38M1.35M131.10%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 114.20M
Black Diamond Therapeutics 70.00M
Spero Therapeutics 66.80M
Fate Therapeutics 6.65M
Alps Group 3.74M
Oramed Pharmaceuticals 2.00M
Molecular Partners AG 856.30K
Spruce Biosciences 697.00K
Revenue Rankings

PRQR News

More News